Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade

Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade

Michelle Przedborski et al. report an integrative systems biology and machine learning method for predicting cancer patient responses to immunotherapy treatment. Using their method, they identify several new drug combinations that could potentially improve treatment protocols for immunotherapy.

Bibliographic Details
Main Authors:	Michelle Przedborski, Munisha Smalley, Saravanan Thiyagarajan, Aaron Goldman, Mohammad Kohandel
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-07-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-021-02393-7

Similar Items

Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics
by: Munisha Smalley, et al.
Published: (2020-06-01)

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer
by: Mengjie Wang, et al.
Published: (2022-04-01)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
by: Xin Wang, et al.
Published: (2019-02-01)

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection
by: Huilin Ou, et al.
Published: (2022-08-01)

An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia.
by: Michelle Przedborski, et al.
Published: (2022-09-01)

Reinforcement learning derived chemotherapeutic schedules for robust patient-specific therapy
by: Brydon Eastman, et al.
Published: (2021-09-01)

Combination approaches with immune checkpoint blockade in cancer therapy
by: Maarten Swart, et al.
Published: (2016-11-01)

Combination immune checkpoint blockade as an effective therapy for mesothelioma
by: Vanessa S. Fear, et al.
Published: (2018-10-01)

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
by: Bogang Wu, et al.
Published: (2018-11-01)

Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
by: Masaki Terabe, et al.
Published: (2017-05-01)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
by: Iris Koopmans, et al.
Published: (2018-08-01)

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
by: Alice L. Hung, et al.
Published: (2018-08-01)

A novel statistical method predicts mutability of the genomic segments of the SARS-CoV-2 virus
by: Amir Hossein Darooneh, et al.
Published: (2022-01-01)

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
by: Weijie Ma, et al.
Published: (2016-05-01)

Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
by: Jan-Michael Werner, et al.
Published: (2019-02-01)

Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
by: Yujie Zhao, et al.
Published: (2022-09-01)

Optimum fractionation of radiation to combine PD‐1 blockade
by: Feifei Teng, et al.
Published: (2023-06-01)

PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma
by: Joshua W. D. Tobin, et al.
Published: (2021-05-01)

PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer
by: Pournima Kadam, et al.
Published: (2020-06-01)

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.
by: Janna Krueger, et al.
Published: (2021-01-01)

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
by: Yuwei Liu, et al.
Published: (2022-06-01)

PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
by: Karla M. Viramontes, et al.
Published: (2022-06-01)

Clinical PD-1/PD-L1 Blockades in Combination Therapies for Lymphomas
by: Hiroo Katsuya, et al.
Published: (2023-11-01)

Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint PD-1/PD-L1
by: Huifang Li, et al.
Published: (2022-09-01)

Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes
by: Dan Zheng, et al.
Published: (2022-07-01)

A Novel Computational Framework for Predicting the Survival of Cancer Patients With PD-1/PD-L1 Checkpoint Blockade Therapy
by: Xiaofan Su, et al.
Published: (2022-06-01)

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade
by: Linan Fang, et al.
Published: (2019-03-01)

Modeling the impact of public response on the COVID-19 pandemic in Ontario.
by: Brydon Eastman, et al.
Published: (2021-01-01)

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
by: Florian Huemer, et al.
Published: (2020-04-01)

Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade
by: Min Hwa Shin, et al.
Published: (2020-04-01)

Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
by: Beckey Trinh, et al.
Published: (2019-02-01)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
by: Yun Hua Lee, et al.
Published: (2020-09-01)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
by: Lin X, et al.
Published: (2021-03-01)

MCT4 blockade increases the efficacy of immune checkpoint blockade
by: Christian Schmidl, et al.
Published: (2023-10-01)

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
by: Robert A. Szczepaniak Sloane, et al.
Published: (2021-10-01)

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
by: Regev, Aviv
Published: (2020)

TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
by: V. Cervera-Carrascon, et al.
Published: (2018-05-01)

Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade
by: Zia Khan, et al.
Published: (2021-06-01)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
by: Paolo A. Ascierto, et al.
Published: (2019-03-01)

CTLA-4 and PD-1 pathway Blockade : Combinations in the Clinic
by: Margaret Kathleen Callahan, et al.
Published: (2015-01-01)